Chief Architects Forum Agenda    (2TCL)

The Chief Architects Forum Quarterly Meeting will be held on Thursday, July 7, 2005 from 1:00 - 4:00 pm at the NOAA Science Center in Silver Spring, MD.    (2TD5)

Please RSVP to Ms. ErinAndrew at    (2TCN)

The Forum will begin promptly at 1:00 PM. Please try to arrive early. Reports from the May 11th CAF Quarterly Meeting will be handed out at this meeting.    (2TCO)

There will also be teleconference capabilities. The following is the call in information:    (2TCP)

Call-in number: 1-877-708-3510 Pass code: 760516#    (2TCQ)

If you have trouble dialing in please call IraGrossman at (301) 266-0157.    (2TCR)

The agenda is below:    (2TCS)

I. Registration/Networking (12:15 - 1:00pm)    (2TCT)

II. Welcome, IraGrossman, Chief Architect NOAA, Chair, Chief Architects Forum    (2TCU)

III. DickBurk, Chief Architect, FEA PMO (1:00 - 1:30pm) Hear on the recently completed assessments, lessons learned, best practices and recommendations moving forward on how agencies can improve. Your "What's on your Mind" questions raised at the last Forum will be answered.    (2TCV)

IV. GaryWashington, FDA Chief Architect (1:30-1:50 pm) FDA has been chosen as OMB's first EA value case study. Learn how to start proving your EA value.    (2TCW)

V. MikeDaconta, DHS Metadata Program Manager and Lead, DRM WG(1:50 - 2:20pm) The DRM is on the fast track and the final version will be complete by December 2005. The Evolution of the Data Reference Model: Moving from the Abstract to the Concrete    (2TMZ)

VI. BillGunnels, CCEA Program Manager and/or RoyRoebuck, CCEA Chief Architect (2:20-2:30 pm) Federal Executive Branch's (National Communications System lead) Continuity of Communication Enterprise Architecture (CCEA) effort - what it means for your agency.    (2TCY)

VII. Networking and break (2:30-2:45 pm)    (2TCZ)

VIII. Break-out Groups (2:45-3:45 pm)    (2TD0)

     A. Discuss feedback for OMB
     B. Your reaction to the DRM direction
     C. More in depth discussion of EA value in light of the FDA case study    (2TD1)

IX. Report outs from groups (3:45-4:00pm)    (2TD2)

X. Closing    (2TD3)